The misfolding and aggregation of the presynaptic protein α-synuclein (AS) into amyloid fibrils is pathognomonic of Parkinson's disease, though the mechanism by which this structural conversion occurs is largely unknown. Soluble oligomeric species that accumulate as intermediates in the process of fibril formation are thought to be highly cytotoxic. Recent studies indicate that oligomer-to-fibril AS transition plays a key role in cell toxicity and progression of neurodegeneration. We previously demonstrated that a subgroup of oligomeric AS species are ordered assemblies possessing a well-defined pattern of intermolecular contacts which are arranged into a distinctive antiparallel β-sheet structure, as opposed to the parallel fibrillar fold....
The analysis of the α-synuclein (aS) aggregation process, which is involved in Parkinson's disease e...
Recent advances in the structural biology of disease-relevant α-synuclein fibrils have revealed a va...
The analysis of the α-synuclein (aS) aggregation process, which is involved in Parkinson's disease ...
The misfolding and aggregation of the presynaptic protein α-synuclein (AS) into amyloid fibrils is p...
Parkinson's disease is an age-related movement disorder characterized by the presence in the mid-bra...
The presence of intraneuronal deposits mainly formed by amyloid fibrils of the presynaptic protein α...
Parkinson's disease is an aged-related movement disorder characterized by the presence in the mid-br...
Alzheimer's disease (AD) is a neurodegenerative disorder occurring in the elderly. It is widely acce...
Alzheimer's disease (AD) is a neurodegenerative disorder occurring in the elderly. It is widely acce...
Structural conversion of the presynaptic, intrinsically disordered protein α-synuclein into amyloid ...
The analysis of the α-synuclein (aS) aggregation process, which is involved in Parkinson's disease e...
SummaryHere, we use single-molecule techniques to study the aggregation of α-synuclein, the protein ...
AbstractStructural conversion of the presynaptic, intrinsically disordered protein α-synuclein into ...
Mechanistic understanding of nucleation dependent polymerization by a-synuclein (alpha-Syn) into tox...
This is the author accepted manuscript. The final version is avialble via PNAS at http://www.pnas.or...
The analysis of the α-synuclein (aS) aggregation process, which is involved in Parkinson's disease e...
Recent advances in the structural biology of disease-relevant α-synuclein fibrils have revealed a va...
The analysis of the α-synuclein (aS) aggregation process, which is involved in Parkinson's disease ...
The misfolding and aggregation of the presynaptic protein α-synuclein (AS) into amyloid fibrils is p...
Parkinson's disease is an age-related movement disorder characterized by the presence in the mid-bra...
The presence of intraneuronal deposits mainly formed by amyloid fibrils of the presynaptic protein α...
Parkinson's disease is an aged-related movement disorder characterized by the presence in the mid-br...
Alzheimer's disease (AD) is a neurodegenerative disorder occurring in the elderly. It is widely acce...
Alzheimer's disease (AD) is a neurodegenerative disorder occurring in the elderly. It is widely acce...
Structural conversion of the presynaptic, intrinsically disordered protein α-synuclein into amyloid ...
The analysis of the α-synuclein (aS) aggregation process, which is involved in Parkinson's disease e...
SummaryHere, we use single-molecule techniques to study the aggregation of α-synuclein, the protein ...
AbstractStructural conversion of the presynaptic, intrinsically disordered protein α-synuclein into ...
Mechanistic understanding of nucleation dependent polymerization by a-synuclein (alpha-Syn) into tox...
This is the author accepted manuscript. The final version is avialble via PNAS at http://www.pnas.or...
The analysis of the α-synuclein (aS) aggregation process, which is involved in Parkinson's disease e...
Recent advances in the structural biology of disease-relevant α-synuclein fibrils have revealed a va...
The analysis of the α-synuclein (aS) aggregation process, which is involved in Parkinson's disease ...